CHOROIDAL THICKNESS IN PATIENTS WITH DIABETIC RETINOPATHY ANALYZED BY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY

Purpose: This study was designed to examine choroidal thickness in patients with diabetes using spectral-domain optical coherence tomography. Methods: Forty-nine patients (49 eyes) with diabetes and 24 age-matched normal subjects underwent high-definition raster scanning using spectral-domain optical coherence tomography with frame enhancement software. Patients with diabetes were classified into 3 groups: 11 patients with mild or moderate nonproliferative diabetic retinopathy and no macular edema, 18 patients with nonproliferative diabetic retinopathy and diabetic macular edema, and 20 patients with treated proliferative diabetic retinopathy and no diabetic macular edema (treated proliferative diabetic retinopathy). Choroidal thickness was measured from the posterior edge of the retinal pigment epithelium to the choroid/sclera junction at 500-μm intervals up to 2,500 μm temporal and nasal to the fovea. Results: Reliable measurements of choroidal thickness were obtainable in 75.3% of eyes examined. Mean choroidal thickness showed a pattern of thinnest choroid nasally, thickening in the subfoveal region, and thinning again temporally in normal subjects and patients with diabetes. Mean subfoveal choroidal thickness was thinner in patients with diabetic macular edema (63.3 μm, 27.2%, P < 0.05) or treated proliferative diabetic retinopathy (69.6 μm, 30.0%, P < 0.01), compared with normal subjects. There was no difference between nonproliferative diabetic retinopathy and normal subjects. Conclusion: Choroidal thickness is altered in diabetes and may be related to the severity of retinopathy. Presence of diabetic macular edema is associated with a significant decrease in the choroidal thickness.

[1]  James G Fujimoto,et al.  Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography. , 2010, American journal of ophthalmology.

[2]  Richard F Spaide,et al.  Age-related choroidal atrophy. , 2009, American journal of ophthalmology.

[3]  D. S. Mcleod,et al.  High-resolution histologic analysis of the human choroidal vasculature. , 1994, Investigative ophthalmology & visual science.

[4]  R. Spaide,et al.  A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. , 2009, American journal of ophthalmology.

[5]  E Reichel,et al.  Topography of diabetic macular edema with optical coherence tomography. , 1998, Ophthalmology.

[6]  D. S. Mcleod,et al.  Intrachoroidal microvascular abnormality: a previously unrecognized form of choroidal neovascularization. , 1996, American journal of ophthalmology.

[7]  A. Fryczkowski,et al.  Changes in the diabetic choroidal vasculature: scanning electron microscopy findings. , 1988, Annals of ophthalmology.

[8]  C. Costagliola,et al.  Enhanced depth imaging spectral-domain optical coherence tomography. , 2010, Retina.

[9]  J. Slakter,et al.  Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. , 2009, American journal of ophthalmology.

[10]  R. Klein,et al.  The 14-year incidence of visual loss in a diabetic population. , 1998, Ophthalmology.

[11]  J. Grunwald,et al.  Foveolar Choroidal Hemodynamics in Proliferative Diabetic Retinopathy , 2004, International Ophthalmology.

[12]  R N Weinreb,et al.  Confocal scanning infrared laser ophthalmoscopy for indocyanine green angiography. , 1995, American journal of ophthalmology.

[13]  Barry Cense,et al.  Histologic correlation of in vivo optical coherence tomography images of the human retina. , 2006, American journal of ophthalmology.

[14]  B. S. Fine,et al.  Diabetic choroidopathy. Light and electron microscopic observations of seven cases. , 1985, Ophthalmology.

[15]  Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. , 1991, Ophthalmology.

[16]  T. Matsuo,et al.  Risk factors for diabetic choroidopathy in patients with diabetic retinopathy , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.

[17]  K. Shiraki,et al.  Age-related scattered hypofluorescent spots on late-phase indocyanine green angiograms , 2004, International Ophthalmology.

[18]  D. Weinberger,et al.  Indocyanine green angiographic findings in nonproliferative diabetic retinopathy. , 1998, American journal of ophthalmology.

[19]  J. Maino,et al.  Hypertensive choroidopathy. , 1982, Journal of the American Optometric Association.

[20]  Y. Ikuno,et al.  Choroidal thickness in healthy Japanese subjects. , 2010, Investigative ophthalmology & visual science.

[21]  R. Klein,et al.  The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. , 1994, Archives of ophthalmology.

[22]  R. Spaide,et al.  ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY OF THE CHOROID IN CENTRAL SEROUS CHORIORETINOPATHY , 2009, Retina.

[23]  T. Hikichi,et al.  Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes , 2004, British Journal of Ophthalmology.

[24]  G. Lutty,et al.  Choriocapillaris degeneration and related pathologic changes in human diabetic eyes. , 1998, Archives of ophthalmology.